By Business/Source
Currency:EUR
2025/Q3
Stock NameRevenueRatio
Discovery and development of innovative, RNA based therapeutics2.88M100.00%
By Country/Region
Currency:EUR
2024/FY
Stock NameRevenueRatio
United States18.91M100.00%